A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
ALLTogether collects the experience of previously successful treatment of infants, children and young adults, with ALL from a number of well-renowned study groups into a new master protocol, which is both a comprehensive system for stratification and treatment of ALL in this age-group as well as the basis for several randomised and interventional trials included in the study-design.
Patients newly diagnosed with T-lymphoblastic (T-cell) or B-lymphoblastic precur... [+8]
Age < 365 days and KMT2A-rearranged (KMT2A-r) BCP-ALL (documented presence of a... [+14]